Global Lysosomal Storage Diseases Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1056

Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.
According to the report, one driver in the market is unmet medical needs.
In 2018, the global Lysosomal Storage Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lysosomal Storage Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Storage Diseases development in United States, Europe and China.

The key players covered in this study
Actelion Pharmaceuticals
BioMarin
Genzyme
Shire
Alexion Pharmaceuticals
Amicus Therapeutics
Chiesi Farmaceutici
Greenovation Biotech And FGK Clinical Research
Horizon Pharma
Leadiant Biosciences
Mylan

Market segment by Type, the product can be split into
Enzyme Replacement Therapy
Substrate Reduction Therapy
Cystine Depleting Agents

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lysosomal Storage Diseases status, future forecast, growth opportunity, key market and key players.
To present the Lysosomal Storage Diseases development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lysosomal Storage Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type (2014-2025)
1.4.2 Enzyme Replacement Therapy
1.4.3 Substrate Reduction Therapy
1.4.4 Cystine Depleting Agents
1.5 Market by Application
1.5.1 Global Lysosomal Storage Diseases Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lysosomal Storage Diseases Market Size
2.2 Lysosomal Storage Diseases Growth Trends by Regions
2.2.1 Lysosomal Storage Diseases Market Size by Regions (2014-2025)
2.2.2 Lysosomal Storage Diseases Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lysosomal Storage Diseases Market Size by Manufacturers
3.1.1 Global Lysosomal Storage Diseases Revenue by Manufacturers (2014-2019)
3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Lysosomal Storage Diseases Key Players Head office and Area Served
3.3 Key Players Lysosomal Storage Diseases Product/Solution/Service
3.4 Date of Enter into Lysosomal Storage Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lysosomal Storage Diseases Market Size by Type (2014-2019)
4.2 Global Lysosomal Storage Diseases Market Size by Application (2014-2019)

5 United States
5.1 United States Lysosomal Storage Diseases Market Size (2014-2019)
5.2 Lysosomal Storage Diseases Key Players in United States
5.3 United States Lysosomal Storage Diseases Market Size by Type
5.4 United States Lysosomal Storage Diseases Market Size by Application

6 Europe
6.1 Europe Lysosomal Storage Diseases Market Size (2014-2019)
6.2 Lysosomal Storage Diseases Key Players in Europe
6.3 Europe Lysosomal Storage Diseases Market Size by Type
6.4 Europe Lysosomal Storage Diseases Market Size by Application

7 China
7.1 China Lysosomal Storage Diseases Market Size (2014-2019)
7.2 Lysosomal Storage Diseases Key Players in China
7.3 China Lysosomal Storage Diseases Market Size by Type
7.4 China Lysosomal Storage Diseases Market Size by Application

8 Japan
8.1 Japan Lysosomal Storage Diseases Market Size (2014-2019)
8.2 Lysosomal Storage Diseases Key Players in Japan
8.3 Japan Lysosomal Storage Diseases Market Size by Type
8.4 Japan Lysosomal Storage Diseases Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lysosomal Storage Diseases Market Size (2014-2019)
9.2 Lysosomal Storage Diseases Key Players in Southeast Asia
9.3 Southeast Asia Lysosomal Storage Diseases Market Size by Type
9.4 Southeast Asia Lysosomal Storage Diseases Market Size by Application

10 India
10.1 India Lysosomal Storage Diseases Market Size (2014-2019)
10.2 Lysosomal Storage Diseases Key Players in India
10.3 India Lysosomal Storage Diseases Market Size by Type
10.4 India Lysosomal Storage Diseases Market Size by Application

11 Central & South America
11.1 Central & South America Lysosomal Storage Diseases Market Size (2014-2019)
11.2 Lysosomal Storage Diseases Key Players in Central & South America
11.3 Central & South America Lysosomal Storage Diseases Market Size by Type
11.4 Central & South America Lysosomal Storage Diseases Market Size by Application

12 International Players Profiles
12.1 Actelion Pharmaceuticals
12.1.1 Actelion Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lysosomal Storage Diseases Introduction
12.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.1.5 Actelion Pharmaceuticals Recent Development
12.2 BioMarin
12.2.1 BioMarin Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lysosomal Storage Diseases Introduction
12.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.2.5 BioMarin Recent Development
12.3 Genzyme
12.3.1 Genzyme Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lysosomal Storage Diseases Introduction
12.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.3.5 Genzyme Recent Development
12.4 Shire
12.4.1 Shire Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lysosomal Storage Diseases Introduction
12.4.4 Shire Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.4.5 Shire Recent Development
12.5 Alexion Pharmaceuticals
12.5.1 Alexion Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lysosomal Storage Diseases Introduction
12.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.5.5 Alexion Pharmaceuticals Recent Development
12.6 Amicus Therapeutics
12.6.1 Amicus Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lysosomal Storage Diseases Introduction
12.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.6.5 Amicus Therapeutics Recent Development
12.7 Chiesi Farmaceutici
12.7.1 Chiesi Farmaceutici Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lysosomal Storage Diseases Introduction
12.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.7.5 Chiesi Farmaceutici Recent Development
12.8 Greenovation Biotech And FGK Clinical Research
12.8.1 Greenovation Biotech And FGK Clinical Research Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lysosomal Storage Diseases Introduction
12.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.8.5 Greenovation Biotech And FGK Clinical Research Recent Development
12.9 Horizon Pharma
12.9.1 Horizon Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lysosomal Storage Diseases Introduction
12.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.9.5 Horizon Pharma Recent Development
12.10 Leadiant Biosciences
12.10.1 Leadiant Biosciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lysosomal Storage Diseases Introduction
12.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.10.5 Leadiant Biosciences Recent Development
12.11 Mylan

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details